Document is current
Any future updates will be listed below
-
Authors
Wang, Shu
Wang, Jingya
Kumar, Varsha
Karnell, Jodi L.
Naiman, Brian
Gross, Phillip S. https://orcid.org/0000-0003-2642-6504
Rahman, Saifur
Zerrouki, Kamelia
Hanna, Richard
Morehouse, Christopher
Holoweckyj, Nicholas
Liu, Hao
,
Casey, Kerry
Smith, Michael
Parker, Melissa
White, Natalie
Riggs, Jeffrey
Ward, Beth
Bhat, Geetha
Rajan, Bhargavi
Grady, Rebecca
Groves, Chris
Manna, Zerai
Goldbach-Mansky, Raphaela
Hasni, Sarfaraz https://orcid.org/0000-0002-4164-8837
Siegel, Richard
Sanjuan, Miguel
Streicher, Katie
Cancro, Michael P.
Kolbeck, Roland
Ettinger, Rachel https://orcid.org/0000-0003-3761-9571
- License Information
-
More Information
Article History
Received: 12 October 2017
Accepted: 8 March 2018
First Online: 1 May 2018
Competing interests
: S.W., J.W., V.K., B.N., S.R., K.Z., R.H., C.M., H.L., N.H., Autoimmunity Molecular Medicine Team, K.S. and R.K. are full-time employees and shareholders of MedImmune/AstraZeneca. R.E. and J.L.K. were employees at MedImmune and owners of AstraZeneca stock. They are currently employees at and shareholder at Viela Bio. The remaining authors declare no competing interests.
